Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer that typically presents as a painless erythematous nodule on body surfaces visible to the sun. Metastatic disease is typical to the lymph nodes, liver, and lungs. There are previous case reports of patients with metastases to the gastrointestinal tract including the stomach, small intestine, and pancreas. To our knowledge, there are only rare occurrences of metastases to the colon. We report a patient with a history of MCC treated with chemotherapy who presented with hematochezia and underwent a colonoscopy that showed a partially obstructing, edematous, friable 7-cm circumferential mass in the transverse colon. Biopsy confirmed the diagnosis of MCC that metastasized to the transverse colon.
INTRODUCTION
Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer that is commonly found in whites who spend time outdoors, are immunocompromised, exposed to Merkel cell polyomavirus, or of older age; MCC is known for its poor prognosis.
1 MCC typically appears as a painless erythematous or violaceous nodule on body surfaces visible to the sun. 1 Metastatic disease is typical to the lymph nodes, liver, and lungs. 1 There are few cases reporting patients with metastases to the gastrointestinal (GI) tract, and to our knowledge, MCC only rarely metastasizes to the colon. We present a patient with MCC that metastasized to the transverse colon.
CASE REPORT
A 71-year-old Hispanic woman with a medical history significant for MCC diagnosed in 2014 and asthma was admitted to our facility for acute asthma exacerbation and found to have systolic heart failure. She subsequently decompensated and was diagnosed with a non-ST segment elevation myocardial infarction. Left heart catheterization showed an ejection fraction of 25%, likely related to stress cardiomyopathy; no significant coronary artery disease was found. The gastroenterology service was consulted for hematochezia and diarrhea that developed while the patient was in the hospital. Her physical examination was normal, and her laboratory values were white blood cell count of 8.9/mL, hemoglobin 10.8 g/dL, hematocrit 33.8%, platelets 240/mL, bilirubin 0.4 mg/dL, aspartate aminotransferase 24 U/L, alanine aminotransferase 31 U/L, and alkaline phosphatase 81 U/L.
The patient presented with a small bowel obstruction in 2014 and was diagnosed with MCC that metastasized to the jejunum, which was resected after receiving neoadjuvant chemotherapy with etoposide and carboplatin. There was no evidence that the patient had active MCC in any other part of her GI tract at that time, including a negative computed tomography of the chest, abdomen, and pelvis. Subsequent colonoscopy performed within 6 months of partial enterectomy did not show any findings of active disease in the colon. She followed up with her oncologist for 2 years after the diagnosis of jejunal metastasis and was subsequently graduated back to her primary care physician. A colonoscopy was completed during the admission in 2018, where a partially obstructing, edematous, and friable 7-cm circumferential mass was found in the transverse colon, without any ulceration being appreciated (Figure 1 
DISCUSSION
MCC is a rare cancer that typically metastasizes to distant lymph nodes, liver, lungs, and bone. 1 There have been few cases reported of MCC metastasizing to other areas of the GI tract apart from the colon. These include the stomach and duodenum; stomach; ileocecal valve; small bowel mesentery; jejunum; stomach, pancreas, and distal duodenum; stomach, jejunum, and ileum; and pancreas. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] To our knowledge, there are only 4 case reports regarding MCC metastasizing to the colon (Table 1) . Our patient is the fifth patient with MCC metastases to the colon, and the second specifically to the transverse colon. This case report is an example of the rarity of MCC metastasizing to the GI tract, particularly the colon, and serves as a reminder that a patient's history is an important marker of prediction of a mass. Biopsy is always warranted in these cases to confirm the diagnosis and allow prompt treatment and follow-up with oncology.
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